The Prange Group and its affiliate Adragos Pharma, one of Europe’s fastest growing CDMOs, has completed the acquisition transaction of Fresenius Kabi production site in Halden, Norway – a leading sterile pharmaceutical manufacturing unit. This strategic move opens the door to considerable new opportunities for growth. This acquisition marks a major milestone for both the […]

The post One of Northern Europe’s Largest Production Sites successfully taken over by the Prange Group and Adragos Pharma first appeared on World Pharma Today.